RENOCRIT 10000 IU INJECTION

Renocrit 10000IU injection is a formulation with active components like Recombinant human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The drug treats anemia triggered by chronic kidney disease (CKD) or chemotherapy for cancer or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of losing blood because of planned surgery and other treatments.
Renocrit 10000IU injection shouldn’t be administered to patients suffering from excessive hypertension or one of the components thereof: active thrombotic microangiopathy (TMA) and Pure red cell cancer (PRCA) uncontrolled seizures as well as lactation or pregnancy. It is also recommended to use it with caution in patients with a previous history of blood clots, heart disease, kidney disease, stroke, liver disorders, thalassemia, sickle cell anemia and myelodysplastic syndrome, cancer, or leukemia. It is not recommended to use for children younger than 18 years old in cases where the benefits are more significant than the risks. Seniors using this medication should be monitored closely for any adverse consequences. Before beginning this medication, you must speak with your doctor regarding the dangers and advantages associated with Renocrit 10000IU injection .